DSCSA compliance for pharmaceutical intermediate procurement
Procurement managers must verify electronic interoperability for DSCSA compliance as unit-level traceability mandates finalise in November 2026.
News
47 of 47
Procurement managers must verify electronic interoperability for DSCSA compliance as unit-level traceability mandates finalise in November 2026.
Examine the impact of the September 2026 CBP advance notice on chemical supply chain transparency, focusing on documentation and item-level traceability.
Understand how the FDA's proposed hub-and-spoke drug registration rules impact fine chemical procurement, documentation requirements, and supply chain audit.
Procurement teams must prepare for potential supply impacts following the ECHA Committee for Risk Assessment's recommendation to classify TFA as reprotoxic.
Evaluate supply chain risks for trifluoroacetic acid (TFA) following the October 2026 ECHA opinion on PMT, vPvM, and Repr. 1B hazard classifications.
Learn how ECHA’s new C&L Inventory notifier transparency impacts supply chain risk assessment for procurement managers specifying fine chemicals.
Understanding the mandatory EU Carbon Border Adjustment Mechanism (CBAM) reporting requirements for procurement managers sourcing chemical precursors and materials.
Understand the impact of EU REACH restrictions on PFHxA levels for chemical procurement and the steps required to audit your raw material supply chain.
Procurement and QA teams must verify supplier testing protocols against 2026 USP revisions to ensure compliance with updated residual solvent and impurity limits.
Understand how the 2026 CMRD revision impacts chemical procurement. Learn to assess supplier compliance regarding new occupational exposure limits for chemicals.
Navigate 2026 USP General Chapter updates including USP <467>, <232>/<233>, and <665> to ensure pharmaceutical raw material compliance and quality assurance.
Understanding the transition of the Ph. Eur. publication schedule to a nine-month implementation window for improved procurement and quality compliance planning.
Navigate the impact of U.S. Section 232 tariffs on pharmaceutical ingredients. Learn how to manage classification, patent status, and landed cost volatility.
Understand how the FDA hub-and-spoke registration model impacts pharmaceutical intermediate procurement, supplier mapping, and risk management strategies.
Procurement and quality teams must verify updated hazard classifications for fine chemicals before the November 1, 2026, EU CLP compliance deadline.
Understand how the July 2026 CLP regulation updates impact chemical procurement, supplier identification, and label compliance for your organisation.
Procurement teams can use the 2026 REACH Restrictions Roadmap to manage supply risks, avoid regrettable substitution, and plan for chemical phase-outs.
Procurement managers must audit supplier SDS and REACH dossiers to meet the November 2026 EU mandate for new endocrine, PBT, and mobile substance hazard classes.
The July 2026 FDA proposal for drug manufacturing registration impacts procurement. Learn how transparency in supply chains mitigates risk for sourcing managers.
Understand the impact of the July 2026 EDQM guideline updates on CEP revisions and how they affect procurement and supplier risk management protocols.
The ECHA C&L Inventory now mandates public disclosure of notifier identities. Learn how this transparency impacts chemical procurement due diligence.
Prepare for the November 2026 DSCSA unit-level traceability deadline. Learn how digital data integrity impacts pharmaceutical chemical supply chain compliance.
The FDA's proposed hub-and-spoke registration impacts how procurement managers qualify suppliers of pharmaceutical intermediates and fine chemicals.
Procurement teams can optimise landed costs using the 2026 EU-US chemical tariff elimination. Learn how to verify U.S. origin for 0% duty applications.
The 2026 EPA scientific framework update streamlines chemical safety via GHS mixture equations and 3D tissue models, aiding procurement and formulation cycles.
Understanding the European Commission's roadmap for non-animal testing and its impact on documentation compliance for fine chemical procurement and QA teams.
Essential guidance for procurement managers on the August 2026 CLP Regulation amendments. Understand how GHS alignment impacts substance classification and audit.
Understand the impact of the new SEC-FDA Memorandum of Understanding on chemical procurement and how it heightens disclosure risks for life sciences sourcing.
Procurement teams must adapt to updated CLP regulations. Digital labelling and flexible B2B format requirements simplify fine chemical sourcing in Europe.
The August 2026 FDA draft guidance on Container Closure Systems mandates rigorous material transparency for pharmaceutical intermediate supply chains.
The EU Packaging and Packaging Waste Regulation (PPWR) now restricts PFAS. Learn how procurement teams must verify material integrity to ensure compliance.
Understand the impact of the EU Packaging and Packaging Waste Regulation on chemical procurement, documentation requirements, and supplier qualification standards.
Procurement managers must adjust strategies for Section 232 pharmaceutical tariffs to manage imported KSM and API costs while maintaining supply chain compliance.
Executive Order 14411 introduces new good standing requirements for U.S. chemical importers. Learn how this impacts procurement strategies and supply security.
Procurement and QA teams must adapt to the U.S. Customs Enforcement Overhaul of 2026. Review new IOR mandates and penalty structures for chemical supply chains.
Procurement and QA teams must assess packaging compliance under the new EU Packaging and Packaging Waste Regulation to avoid import rejection and delays.
Examine the impact of Regulation (EU) 2024/2865 on your chemical supply chain, including new requirements for EU-based supplier details and digital labelling.
Understand how the August 2026 FDA proposed rule on hub-and-spoke manufacturing affects your procurement of pharmaceutical intermediates and supply chain audits.
The EU Packaging and Packaging Waste Regulation is now in force. Procurement managers must audit secondary packaging for PFAS and heavy metal compliance.
Understand the impact of mandatory FDA GRAS notifications on chemical procurement. Learn how to update supplier documentation to ensure regulatory compliance.
Learn how the proposed FDA rule on mandatory GRAS notifications affects your procurement strategy, supplier vetting, and chemical compliance documentation.
Procurement and QA teams must address new US Customs enforcement mandates. The mandatory 50 percent penalty requires stricter documentation for all chemical imports.
Understanding the impact of CLP Regulation EU 2024/2865 on procurement, classification of Substances with More Than One Constituent, and updated safety documentation.
Understand the new CLP requirements for small-packaging products under 10ml effective July 2026. Ensure your chemical procurement strategy meets EU standards.
A CoA is the only document that describes the material you actually received. Here is what each part of one means, and the four checks worth making before the drum is opened.
An SDS is written for the people handling the material. Five of its sixteen sections decide things a purchaser cares about — including one that changes your freight cost.
Two lots can both certify at 99.5% and behave differently in the same process. The assay tells you how much of the substance is there. It says nothing about what the rest is.
